Benzodiazepines as a Monotherapy in Depressive Disorders: A Systematic Review
The DOI matches its Crossref record; 65 of the 66 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The aim of this paper was to perform a systematic review and, when feasible, a meta-analysis of randomized controlled trials (RCT) which used benzodiazepines (BZD) as a monotherapy versus placebo, antidepressant drugs (AD), or both. METHODS: Keyword searches were conducted for identifying RCT comparing BZD and AD, and/or placebo in the treatment of depression, using electronic databases from their inception up to April 2017. We selected reports of RCT in which BZD were compared to AD and/or placebo in the treatment of adult patients with a primary diagnosis of depressive disorder or anxious depression. When feasible, data were subjected to meta-analysis. RESULTS: A total of 38 studies met the criteria for inclusion and were then included in the systematic review. Only 1 study concerned a newer AD, fluvoxamine. For the meta-analysis, we submitted data on response rate from 22 RCT, considering BZD versus placebo (8 comparisons) and BZD versus tricyclic antidepressants (TCA) (20 comparisons). There was a lack of significant differences as to response rate between BZD and placebo, as well as between BZD and TCA. Analysis of individual studies disclosed that, in more than half of the studies comparing BZD to TCA and/or placebo, BZD were significantly more effective than placebo and as effective as TCA. CONCLUSIONS: BZD are a therapeutic option in anxious depression and there are no indications that AD are preferable. There is a pressing need for RCT of adequate methodological quality and follow-up comparing BZD to second-generation AD and placebo in anxious depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, BZD have been evaluated as monotherapy for depression with no observed difference from tricyclic antidepressants (TCA) in a meta-analysis of 20 trials from the 1970's to early 1990's.140”
In the citing paper
“It should also be remembered that benzodiazepines were found to be effective in anxious and mild depression.77”
From May antidepressant drugs worsen the conditions they are supposed to treat? The clinical foundations of the oppositional model of tolerance (2020) · cites this paper as [77]
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
The combination of estimates from different experiments
Cochran, W. G. (1954) · Biometrics · doi:10.2307/3001666 · Cited by 5,380
Selective publication of antidepressant trials and its influence on apparent efficacy
Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., & Rosenthal, R. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa065779 · Cited by 2,435
Antidepressant Drug Effects and Depression Severity: A Patient-Level Meta-analysis
Fournier, J. C., DeRubeis, R. J., Hollon, S. D., Dimidjian, S., Amsterdam, J. D., Shelton, R. C., & Fawcett, J. (2010) · JAMA · doi:10.1001/jama.2009.1943 · Cited by 2,009
Fava, M., Rush, A. J., Alpert, J. E., Balasubramani, G. K., Wisniewski, S. R., Carmin, C. N., Biggs, M. M., Zisook, S., Leuchter, A., Howland, R., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06111868 · Cited by 927
Carvalho, A. F., Sharma, M. S., Brunoni, A. R., Vieta, E., & Fava, G. A. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447034 · Cited by 650
Self-citationKessler, R. C., Sampson, N. A., Berglund, P., Gruber, M. J., Al-Hamzawi, A., Andrade, L., Bunting, B., Demyttenaere, K., Florescu, S., de Girolamo, G., et al. (2015) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796015000189 · Cited by 636
Bauer, M., Pfennig, A., Severus, E., Whybrow, P. C., Angst, J., Möller, H.-J., & Šon behalf of the Task Force on Unipolar Depressive Disorders (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.804195 · Cited by 632
Antidepressant discontinuation reactions: Are preventable and simple to treat
Haddad, P., Lejoyeux, M., & Young, A. (1998) · BMJ · doi:10.1136/bmj.316.7138.1105 · Cited by 286
Kahn, R. J. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800010081010 · Cited by 278
Barbui, C., Cipriani, A., Patel, V., Ayuso-Mateos, J. L., & van Ommeren, M. (2011) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.076448 · Cited by 218
Comparison of Alprazolam, Imipramine, and Placebo in the Treatment of Depression
Feighner, J. P. (1983) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1983.03330460039029 · Cited by 203
Offidani, E., Guidi, J., Tomba, E., & Fava, G. A. (2013) · Psychotherapy and Psychosomatics · doi:10.1159/000353198 · Cited by 166
Self-citationNew Classification of Selective Serotonin Reuptake Inhibitor Withdrawal
Chouinard, G., & Chouinard, V.-A. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000371865 · Cited by 164
Benzodiazepines as antidepressants: Does GABA play a role in depression?
Petty, F., Trivedi, M. H., Fulton, M., & Rush, A. J. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(95)00049-7 · Cited by 146
Alprazolam, Amitriptyline, Doxepin, and Placebo in the Treatment of Depression
Rickels, K. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790250028004 · Cited by 146
Benzodiazepines in Depressive Disorders
Schatzberg, A. F. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770350085008 · Cited by 137
Alprazolam, Diazepam, Imipramine, and Placebo in Outpatients With Major Depression
Rickels, K. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800220024005 · Cited by 109
Nielsen, M., Hansen, E. H., & Gøtzsche, P. C. (2012) · Addiction · doi:10.1111/j.1360-0443.2011.03686.x · Cited by 103
Maslej, M. M., Bolker, B. M., Russell, M. J., Eaton, K., Durisko, Z., Hollon, S. D., Swanson, G. M., Thomson Jr., J. A., Mulsant, B. H., & Andrews, P. W. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000477940 · Cited by 98
Fava, G. A., Guidi, J., Rafanelli, C., & Rickels, K. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000480038 · Cited by 93
Self-citationThe reappraisal of benzodiazepines in the treatment of anxiety and related disorders
Starcevic, V. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.963057 · Cited by 90
Is antidepressant–benzodiazepine combination therapy clinically more useful?
Furukawa, T. A., Streiner, D. L., & Young, L. T. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00254-8 · Cited by 87
Pharmacological treatment for generalized anxiety disorder in adults: an update
Reinhold, J. A., & Rickels, K. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1059424 · Cited by 82
Mixed Anxiety-Depression: Fact or Myth?
Downing, R. W. (1974) · Archives of General Psychiatry · doi:10.1001/archpsyc.1974.01760090030005 · Cited by 74
Benzodiazepines for depression? A review of the literature
Birkenhäger, T. K., Moleman, P., & Nolen, W. A. (1995) · International Clinical Psychopharmacology · doi:10.1097/00004850-199510030-00008 · Cited by 67
Amsterdam, J. D., Kaplan, M. J., Potter, L. S., Bloom, L. H., & Rickels, K. (1986) · Psychopharmacology · doi:10.1007/bf00178511 · Cited by 60
Laws, D., Ashford, J. J., & Anstee, J. A. (1990) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1990.tb06476.x · Cited by 59
Cloos, J.-M., Bocquet, V., Rolland-Portal, I., Koch, P., & Chouinard, G. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000434755 · Cited by 57
Alprazolam vs Amitriptyline in Depressions With Reduced REM Latencies
Rush, A. J. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790350028006 · Cited by 57
Clinical Pharmacopsychology: Conceptual Foundations and Emerging Tasks
Fava, G. A., Tomba, E., & Bech, P. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000458458 · Cited by 52
Self-citationDifferential drug effects in neurotic depression.
Rickels, K., Hesbacher, P. T., & Rw, D. (1970) · PubMed · Cited by 36
Rickels, K., Perloff, M. M., Stepansky, W., Dion, H., CASE, W. G., & Sapra, R. K. (1969) · Psychopharmacology · doi:10.1007/bf00401681 · Cited by 35
Variation in results from randomized, controlled trials: stochastic or systematic?
Jane-wit, D., Horwitz, R. I., & Concato, J. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.02.010 · Cited by 33
Comparison of alprazolam and imipramine for treatment of outpatient depression.
Overall, J. E., Biggs, J. T., Jacobs, M., & Holden, K. (1987) · PubMed · Cited by 29
Treatment of depressive outpatients with lorazepam, alprazolam, amytriptyline and placebo
Laakmann, G., Faltermaier-Temizel, M., Bossert-Zaudig, S., Baghai, T. C., & Lorkowski, G. (1995) · Psychopharmacology · doi:10.1007/bf02246151 · Cited by 28
The use of benzodiazepines in depression.
Johnson, D. (1985) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1985.tb02740.x · Cited by 28
Singh, A., Nair, N. P. V., Suranyi-Cadotte, B. E., Schwartz, G. J., & Lizondo, E. (1988) · The Canadian Journal of Psychiatry · doi:10.1177/070674378803300311 · Cited by 27
Double-blind clinical study comparing alprazolam and doxepin in primary unipolar depression
Ansseau, M., Ansoms, C., Beckers, G., Bogaerts, M., Botte, L., Buck, R. D., Diricq, S., Dumortier, A., Jansegers, E., Owieczka, J., et al. (1984) · Journal of Affective Disorders · doi:10.1016/0165-0327(84)90050-8 · Cited by 26
The hidden costs of financial conflicts of interest in medicine
Fava, G. A. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000442694 · Cited by 25
MENDELS, J., & Schless, A. P. (1986) · PubMed · Cited by 25
Hubain, P., Castro, P., Mesters, P., Maertelaer, V. D., & Mendlewicz, J. (1990) · Journal of Affective Disorders · doi:10.1016/0165-0327(90)90118-r · Cited by 23
Ansseau, M., Devoitille, J.-M., Papart, P., Vanbrabant, E., Mantanus, H., & Timsit-Berthier, M. (1991) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199106000-00003 · Cited by 23
A Comparison of the Efficacy and Safety of Alprazolam and Desipramine in Depressed Outpatients
Remick, R. A., Keller, F.-E., Buchanan, R. A., Gibson, R. E., & Fleming, J. A. E. (1988) · The Canadian Journal of Psychiatry · doi:10.1177/070674378803300703 · Cited by 23
Alprazolam compared to amitriptyline in the treatment of major depression
Eriksson, B., Nagy, Á., Starmark, J.-E., & Thelander, U. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb02851.x · Cited by 22
Rj, K. (1979) · PubMed · Cited by 21
Controlled comparison of bromazepam, amitriptyline, and placebo in anxiety-depressive neurosis.
Shammas, E. (1977) · PubMed · Cited by 20
Adinazolam, Diazepam, Imipramine, and Placebo in Major Depressive Disorder: A Controlled Study*
Rickels, K., London, J., Fox, I., Hassman, H. H., Csanalosi, I., & Weise, C. (1991) · Pharmacopsychiatry · doi:10.1055/s-2007-1014455 · Cited by 18
AMITRIPTYLINE, DIAZEPAM, AND PHENOBARBITAL SODIUM IN DEPRESSED OUTPATIENTS
Rickels, K., Chung, H. R., FELDMAN, H. S., Gordon, P. E., & Kelly, E. (1973) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-197312000-00006 · Cited by 18
Rh, L., Je, S., Peyser, J. M., Jm, W., & Weaver, L. A. (1984) · PubMed · Cited by 18
Alprazolam versus imipramine in depressed out-patients with neurovegetative signs
Goldberg, S. C., Ettigi, P. G., Schulz, P. M., Hamer, R. M., Hayes, P. E., & Friedel, R. O. (1986) · Journal of Affective Disorders · doi:10.1016/0165-0327(86)90020-0 · Cited by 17
Smith, W. T., & Glaudin, V. (1986) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1986.tb06239.x · Cited by 16
Comparison of adinazolam, amitriptyline, and placebo in the treatment of melancholic depression
Hicks, F. G., Robins, E., & Murphy, G. E. (1988) · Psychiatry Research · doi:10.1016/0165-1781(88)90012-1 · Cited by 16
Remick, R. A., Fleming, J. A. E., Buchanan, R. A., Keller, F.-E., Hamilton, P. G., Loomer, F., & Miles, J. (1985) · The Canadian Journal of Psychiatry · doi:10.1177/070674378503000808 · Cited by 16
Benzodiazepines in Anxiety Disorders
Fava, G. A., Balon, R., & Rickels, K. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.0182 · Cited by 14
Adinazolam mesylate and placebo in depressed outpatients: a 6-week, double-blind comparison.
Jb, C., Pyke, R. E., & Cs, W. (1988) · PubMed · Cited by 14
Alprazolam and amitriptyline in the treatment of moderate depression
Lapierre, Y. D., Browne, M., Oyewumi, K., & Sarantidis, D. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199400910-00007 · Cited by 12
Cropper, M., Garner, A., Gd, M., Munt, D. F., La, R., Stevens, & Ac, B. (1987) · PubMed · Cited by 12
Not Again: Benzodiazepines Once More Under Attack
Salzman, C., & Shader, R. I. (2015) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000383 · Cited by 11
Banerji, J. R., Brantingham, P., Gd, M., Mason, J. O., Munt, D. F., Renton, R., Scott, A. P. B., Strakova, J. M., & Stevens, V. (1989) · Irish Journal of Medical Science (1971 -) · doi:10.1007/bf02943038 · Cited by 10
Psychotropic Drug Treatment of Mixed Anxiety and Depression in Nonpsychiatric Office Patients
Goldstein, B. J., Brauzer, B., Steinbook, R. M., & Jacobson, A. F. (1973) · Southern Medical Journal · doi:10.1097/00007611-197308000-00011 · Cited by 9
Lemoine, P., Boulenger, J.-P., Caillard, V., Tanne, N., & BONNET, D. (1991) · Pharmacopsychiatry · doi:10.1055/s-2007-1014464 · Cited by 7
A double-blind evaluation of alprazolam and imipramine in the treatment of major depression.
Murthy, R. S., Chatterjee, S., Sriram, T. G., Lp, S., Parikh, R. M., Elavia, S., Gc, M., Nehru, R., Ramachandran, Nirmala, G., et al. (1991) · Europe PMC (PubMed Central) · Cited by 5
Double-blind drug study in depressed outpatients.
Yamamoto, J., KLINE, F. M., & Burgoyne, R. W. (1972) · PubMed · Cited by 3
Cited by
Als, T. D., Kurki, M. I., Grove, J., Voloudakis, G., Therrien, K., Tasanko, E., Nielsen, T. T., Naamanka, J., Veerapen, K., Levey, D. F., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02352-1 · Cited by 324
Clinical characterization of allostatic overload
Fava, G. A., McEwen, B. S., Guidi, J., Gostoli, S., Offidani, E., & Sonino, N. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.05.028 · Cited by 265
“, 2018) and in affective disorders (Benasi et al., 2018).”
Prévot, T., & Sibille, E. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-0727-3 · Cited by 231
Benzodiazepines Remain Important Therapeutic Options in Psychiatric Practice
Dubovsky, S. L., & Marshall, D. (2022) · Psychotherapy and Psychosomatics · doi:10.1159/000524400 · Cited by 171
Allopregnanolone in postpartum depression: Role in pathophysiology and treatment
Meltzer-Brody, S., & Kanes, S. J. (2020) · Neurobiology of Stress · doi:10.1016/j.ynstr.2020.100212 · Cited by 133
“As a monotherapy for MDD, few randomized controlled trials have examined benzodiazepines since the 1990s, and meta-analyses of these studies show no significant response rate versus placebo in depressive disorders (Benasi et al., 2018).”
Metadata
- Authors
- Benasi, G., Guidi, J., Offidani, E., Balon, R., Rickels, K., & Fava, G. A.
- Affiliations
- University of Bologna (IT)
- Pennsylvania State University (US)
- Wayne State University (US)
- University of Pennsylvania (US)
- University at Buffalo, State University of New York (US)
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2018
- Volume
- 87
- Issue
- 2
- Pages
- 65-74
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W2790662831
- Cited by
- 79
- References
- 66
- Citations by year
- 2026: 4 · 2025: 12 · 2024: 8 · 2023: 4 · 2022: 7 · 2021: 14 · 2020: 13 · 2019: 14 · 2018: 3
- FWCI
- 1.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- karger.com/pages/terms-and-conditions (vor)
- karger.com/pages/terms-and-conditions (tdm)
- Locations
- Psychotherapy and Psychosomatics (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- benzodiazepines, depression, monotherapy, antidepressants, tricyclic antidepressants, anxious depression, placebo comparison, treatment response rate, fluvoxamine, second-generation antidepressants
- MeSH terms
- Antidepressive Agents, Tricyclic, Benzodiazepines, Major Depressive Disorder, Humans, Randomized Controlled Trials as Topic, Selective Serotonin Reuptake Inhibitors, Antidepressive Agents, Second-Generation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.